The Kaplan–Meier analysis of SRCIN1 gene expression on the R2 platform, containing gene expression profiles and clinical information of 498 NB cases compared to overall survival (OS) and event-free survival (EFS), showed that high SRCIN1 expression was significantly associated with good prognosis (403 patients) whereas low expression was observed in 95 poor prognosis patients (Fig. 4, panel b). The gene discussed is SRCIN1; the disease is neuroblastoma.